Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I ReceptorJoan M. Carboni, Tai W. Wong|Cancer Research|2005Cited by 203
High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR TherapyBeate C. Litzenburger, Adrian V. Lee, Anna Tsimelzon et al.|Clinical Cancer Research|2010Cited by 131